Skip to content
10-Q

Quarterly Report

MEDINOTEC, INC. MDNC

0001663577-24-000081

← back to feed
Filed
Mar 14, 2024 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2024 · Dec 18, 2023 11.73M sh
Current Liabilities Q3 2024 · Nov 30, 2023 $336.19K
Current Liabilities Q3 2024 · Feb 28, 2023 $71.31K
Total Liabilities Q3 2024 · Nov 30, 2023 $1.92M
Total Liabilities Q3 2024 · Feb 28, 2023 $1.93M
Current Assets Q3 2024 · Nov 30, 2023 $3.59M
Current Assets Q3 2024 · Feb 28, 2023 $3.37M
Total Assets Q3 2024 · Nov 30, 2023 $3.99M
Total Assets Q3 2024 · Feb 28, 2023 $4.49M
Capex Q3 2024 · Nov 30, 2022 $57.04K
Operating Cash Flow Q3 2024 · Nov 30, 2022 −$848.14K
Cash And Equivalents Q3 2024 · Nov 30, 2022 $2.85M
Cash And Equivalents Q3 2024 · Feb 28, 2022 $131.57K
Eps Basic Q3 2024 · Nov 30, 2022 $0.00
Eps Basic Q3 2024 · Nov 30, 2022 $0.00
Sga Expense Q3 2024 · Nov 30, 2022 $159.82K
Sga Expense restated Q3 2024 · Nov 30, 2022 $461.79K
Rd Expense Q3 2024 · Nov 30, 2022 $6.41K
Rd Expense restated Q3 2024 · Nov 30, 2022 $62.36K
Net Income Q3 2024 · Nov 30, 2022 −$36.34K
Net Income Q3 2024 · Nov 30, 2022 −$289.08K
Operating Income Q3 2024 · Nov 30, 2022 $25.5K
Operating Income Q3 2024 · Nov 30, 2022 −$195.09K
Gross Profit Q3 2024 · Nov 30, 2022 $223.3K
Gross Profit Q3 2024 · Nov 30, 2022 $420.2K
Cost Of Revenue Q3 2024 · Nov 30, 2022 $164.69K
Cost Of Revenue restated Q3 2024 · Nov 30, 2022 $300.14K
Revenue Q3 2024 · Nov 30, 2022 $387.99K
Revenue Q3 2024 · Nov 30, 2022 $720.34K